MK0431-023

null · Merck Sharp & Dohme LLC

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for MK0431-023, covering 2010-07-21 to 2010-07-21. Get the full timeline:

Most recent: Clinical Trial Update: An Investigational Drug Study in Patients With Type 2 Diabetes Mellitus (MK0431-023) [Phase 3]